A novel in vitro prognostic model of bladder cancer based on urine-derived living tumor cells

Bladder cancer (BLCA) remains a difficult malignancy to manage because of its high recurrence, intense follow-up, and invasive diagnostic and treatment techniques. Immune checkpoint inhibitors (ICIs) have forged a new direction for the treatment of BLCA, but it is currently challenging to predict wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiaqi, Zhu, Jiying, Hu, Junchi, Wang, Ziruoyu, Wang, Xiaobo, Pan, Jianbo, Chu, Yiwei, Li, Zengxia, Jiang, Wei, Liang, Chunmin, Hou, Jun, Guo, Jianming, Dang, Yongjun, Jiang, Shuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405094/
https://www.ncbi.nlm.nih.gov/pubmed/37554182
http://dx.doi.org/10.1016/j.gendis.2022.10.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405094/
https://www.ncbi.nlm.nih.gov/pubmed/37554182
http://dx.doi.org/10.1016/j.gendis.2022.10.022

Ejemplares similares